Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar 15;225(6):1021-1031.
doi: 10.1093/infdis/jiab567.

Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV

Geraldo Duarte  1 , Petronella Muresan  2 , Shawn Ward  2 , Lauren Laimon  3 , Stephen I Pelton  4 , Jennifer Canniff  5 , Amanda Golner  6 , Frederic Bone  6 , Lassallete Newton  3 , Terence Fenton  2 , Conrado M Coutinho  1 , Esau C João  7 , Breno R Santos  8 , Jose H Pilotto  9 , Ricardo H Oliveira  10 , Jorge A Pinto  11 , Elizabeth S Machado  10 , Regis Kreitchman  12 , Nahida Chakhtoura  13 , Marisa M Mussi-Pinhata  14 , Adriana Weinberg  5
Affiliations
Randomized Controlled Trial

Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV

Geraldo Duarte et al. J Infect Dis. .

Abstract

Background: Pneumococcal vaccination is recommended in people with HIV, prioritizing PCV. We compared the immunogenicity of PCV-10 and PPV-23 administered antepartum or postpartum.

Methods: This double-blind study randomized 346 pregnant women with HIV on antiretrovirals to PCV-10, PPV-23, or placebo at 14-34 weeks gestational age. Women who received placebo antepartum were randomized at 24 weeks postpartum to PCV-10 or PPV-23. Antibodies against 7 serotypes common to both vaccines and 1 serotype only in PPV-23 were measured by ELISA/chemiluminescence; B- and T-cell responses to serotype 1 by FLUOROSPOT; and plasma cytokines/chemokines by chemiluminescence.

Results: Antibody responses were higher after postpartum versus antepartum vaccination. PCV-10 generated lower antibody levels than PPV-23 against 4 and higher against 1 of 7 common serotypes. Additional factors associated with high postvaccination antibody concentrations were high prevaccination antibody concentrations and CD4+ cells; low CD8+ cells and plasma HIV RNA; and several plasma cytokines/chemokines. Serotype 1 B- and T-cell memory did not increase after vaccination.

Conclusions: Antepartum immunization generated suboptimal antibody responses, suggesting that postpartum booster doses may be beneficial and warrant further studies. Considering that PCV-10 and PPV-23 had similar immunogenicity, but PPV-23 covered more serotypes, use of PPV-23 may be prioritized in women with HIV on antiretroviral therapy.

Clinical trails registration: NCT02717494.

Keywords: ART; HIV infection; PCV; PPV; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Consort diagram.
Figure 2.
Figure 2.
Antibody responses to PCV-10 and PPV-23 administered antepartum or postpartum. Data were derived from 336 women with HIV randomly assigned to PCV-10 antepartum (n = 115), PPV-23 antepartum (n = 115), PCV-10 postpartum (n = 53), and PPV-23 postpartum (n = 53). The following serotypes showed significant differences (P ≤ .03) in the unadjusted nonparametric comparison of week 4 postvaccination antibody concentrations antepartum versus postpartum: 1, PCV-10 and PPV-23; 4, PCV-10 and PPV-23; 5, PCV-10 and PPV-23; 7F, PPV-23; 14, PPV-23; 23F, PPV-23; and 33F, PPV-23. The following serotypes showed significant differences in the unadjusted comparison of PCV-10 versus PPV-23 antibody concentrations at 4 weeks after vaccination: 1, antepartum and postpartum; 4, antepartum and postpartum; 7F, postpartum; and 14, postpartum. Maternal geometric means and 95% confidence intervals are shown.
See this image and copyright information in PMC

References

    1. Yin Z, Rice BD, Waight P, et al. . Invasive pneumococcal disease among HIV-positive individuals, 2000–2009. AIDS 2012; 26:87–94. - PubMed
    1. Kirwan PD, Amin-Chowdhury Z, Croxford SE, et al. . Invasive pneumococcal disease in people with human immunodeficiency virus in England, 1999–2017. Clin Infect Dis 2021; 73:91–100. - PubMed
    1. Deutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C, Schrag S; Active Bacterial Core Surveillance Team. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53:114–23. - PubMed
    1. ACOG committee opinion no. 741: maternal immunization. Obstet Gynecol 2018; 131:e214–e7. - PubMed
    1. Pilishvili T, Bennett NM.. Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. Am J Prev Med 2015; 49:S383–90. - PubMed

Publication types

Associated data